Medical Xpress·3 min read·medium
GLP-1 diabetes drugs linked to up to 68% higher hair loss risk
B
British Medical Journal
✦AI Summary
A study published in The BMJ suggests that GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, are linked to a higher risk of hair loss. Researchers compared patient data from over 27,000 individuals to determine the association between these medications and alopecia.
edited by Sadie Harley , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in